- Home
- WFF vs ICCM Comparison
WFF vs ICCM Comparison
Compare WFF & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WFF | ICCM |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | Malaysia | Israel |
| Employees | 142 | N/A |
| Industry | Miscellaneous manufacturing industries | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 20.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | WFF | ICCM |
|---|---|---|
| Price | $2.37 | $3.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 14.6K | ★ 83.1K |
| Earning Date | 05-24-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.13 |
| 52 Week High | $3.15 | $9.54 |
Technical Indicators
Market Signals| Indicator | WFF | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 45.88 |
| Support Level | $0.38 | $2.71 |
| Resistance Level | $3.08 | $5.69 |
| Average True Range (ATR) | 0.18 | 0.28 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 100.00 | 43.02 |
Price Performance
Historical ComparisonAbout WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.